The term neurological condition is used to describe any disorder of the body’s nervous system and covers a variety of structural, biochemical or electrical abnormalities in the brain, spinal cord, or other nerves. Neurological conditions can result in a range of symptoms including paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain, and altered levels of consciousness.
Stem cell therapy may be used to address the tissue damage and inflammation caused by neurological conditions. Stem cells harvested from a patient’s adipose (fat) have the potential to replace numerous cells within the body and alleviate the debilitating, painful effects of these conditions, which are often difficult to manage.
As part of Regenerative Cell Institute’s stem cell therapy for neurological conditions, stem cells are first harvested from a patient and prepared for injection, using propriety methods that yield the highest concentrations of regenerative cells. Stem cells are then administered one of three ways: intravenously (injected directly into the vein), direct injection (into site needing repair), or intraspinal injections. To ensure the delivery of the highest quantity of activated stem cells, Dr. Santos personally evaluates each patient to assess their condition and develop a customized treatment plan which includes the preferred method of stem cell harvesting and method of administration.
As one of the leaders in the field of stem cell therapy, Dr. Santos understands the science behind stem cell therapy for neurological conditions. At the Regenerative Cell Institutes of Las Vegas, Nevada, and Mason City, Iowa, Dr. Santos evaluates each patient to assess their condition and develop a targeted treatment plan to address their condition.
To schedule a consultation at one of our stem cell treatment centers, or to learn more about our stem cell treatments for Multiple Sclerosis, Muscular Dystrophy, Parkinson’s Disease, stroke recovery, Alzheimer’s Disease, and Autism, please contact the Regenerative Cell Institute.